Internal Medicine, Endocrinology, Diabetes, & Metabolism · Niagara Falls, NY
NPI
1720069735
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
621 10th St
Niagara Falls, NY, 14301
Phone (716) 284-7634
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
849 services
Medicare patients, 2024
215
Average age 73
Drug cost, 2024
$2.8M
7,527 prescriptions
Company payments, 2025
$325
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anita Chaudhuri was code 99214 (office e&m - established), 436 times for 164 patients. In total Anita Chaudhuri billed 849 services in 7 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 436 | 164 | $79.26 | $35K |
| 99213 Office E&M - Established | Office | 246 | 144 | $54.46 | $13K |
| 95251 Test - Miscellaneous | Office | 142 | 42 | $23.51 | $3,338 |
| 99204 Office E&M - New | Office | 11 | 11 | $102.89 | $1,132 |
By year: 2022 $66K for 830 services; 2023 $57K for 775 services; 2024 $53K for 849 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anita Chaudhuri prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 675 prescriptions and refills. In total Anita Chaudhuri wrote 7,527 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 675 | 1,150 | 121 | $51K |
| Levothyroxine Sodium Generic | 549 | 1,187 | 131 | $7,797 |
| Trulicity Dulaglutide | 528 | 679 | 112 | $643K |
| Metformin Hcl Generic | 490 | 1,294 | 154 | $6,748 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 443 | 861 | 125 | $58K |
| Levoxyl Levothyroxine Sodium | 416 | 733 | 75 | $16K |
| Jardiance Empagliflozin | 385 | 553 | 76 | $318K |
| Humalog Kwikpen U-100 Insulin Lispro | 362 | 576 | 107 | $101K |
| Ozempic Semaglutide | 306 | 369 | 75 | $334K |
| Glipizide Generic | 279 | 638 | 79 | $3,188 |
| Unithroid Levothyroxine Sodium | 228 | 386 | 50 | $14K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 210 | 358 | 64 | $20K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 200 | 307 | 63 | $47K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 180 | 307 | 45 | $165K |
| Farxiga Dapagliflozin Propanediol | 175 | 257 | 31 | $145K |
Brand drugs: 5,163 claims; generic drugs: 1,720 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anita Chaudhuri $325 ($325 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novo Nordisk Inc with $84.59.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.